Close

VSV8

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This octapeptide is amino acids 52 to 59 fragment of the the vesicular stomatitis virus (VSV) nucleoprotein. VSV-8 is derived from the VSV nucleoprotein that is expressed in the cytosol of the infected cells. CTL response against VSV in H-2Kb mice is directed against this single VSV-8 immunodominant peptide. This peptide forms complex with murine MHC class I molecule H-2Kb, which is similar to human HLA class I.

Associated Disease
  • VSV Infection
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-L121 Human anti-VSV8 (RGYVYQGL) T Cell Receptor, pMSGV1 VSIV Human RGYVYQGL retroviral vector   Add to Cart   Datasheet
TCR-L120Z Human anti-vesicular stomatitis virus octapeptide (VSV8) (aa 52-59) T cell receptor, pCDTCR1 VSIV Human RGYVYQGL Lentiviral   Add to Cart   Datasheet
TCR-C257Z Mouse anti-VSV8 T cell receptor (BM3.3), pCDTCR1 VSIV BM3.3 Mouse RGYVYQGL H-2Kb Lentiviral   Add to Cart   Datasheet
TCR-C258Z Mouse anti-VSV8 T cell receptor (N15), pCDTCR1 VSIV N15 Mouse RGYVYQGL H-2Kb Lentiviral   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.